Back
Adaptive Biotechnologies Vs. Omnicell Industry Stock Comparison
Buy
63
ADPT
Adaptive Biotechnologies
Last Price:
4.84
Seasonality Move:
8.94%
Buy
69
OMCL
Omnicell
Last Price:
48.74
Seasonality Move:
3.33%
Buy
63
Adaptive Biotechnologies (ADPT)
is a Buy
Is Adaptive Biotechnologies a Buy, Sell or Hold?
- The current Adaptive Biotechnologies [ADPT] share price is $5.06. The Score for ADPT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- ADPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Omnicell (OMCL)
is a Buy
Is Omnicell a Buy, Sell or Hold?
- The current Omnicell [OMCL] share price is $53.08. The Score for OMCL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- OMCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADPT Stock Price Chart
What is Adaptive Biotechnologies's stock price today?
-
The Adaptive Biotechnologies share price today is $5.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
OMCL Stock Price Chart
ADPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 57.84 | Buy |
| Chaikin Money Flow: | 490216 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.57 - 5.19) | Buy |
| Bollinger Bands (100): | (3.74 - 4.9) | Buy |
OMCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 77.8 | Buy |
| Chaikin Money Flow: | 1224414 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.71 - 44.73) | Buy |
| Bollinger Bands (100): | (29.66 - 44.6) | Buy |
ADPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.67 | Buy |
| 20-day SMA: | 4.9 | Buy |
| 50-day SMA: | 4.7 | Buy |
| 200-day SMA: | 3.88 | Buy |
| 8-day EMA: | 4.76 | Buy |
| 20-day EMA: | 4.78 | Buy |
| 50-day EMA: | 4.67 | Buy |
| 200-day EMA: | 4.43 | Buy |
OMCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.73 | Buy |
| 20-day SMA: | 42.08 | Buy |
| 50-day SMA: | 43.14 | Buy |
| 200-day SMA: | 33.28 | Buy |
| 8-day EMA: | 43.23 | Buy |
| 20-day EMA: | 42.42 | Buy |
| 50-day EMA: | 41.45 | Buy |
| 200-day EMA: | 38.22 | Buy |
Adaptive Biotechnologies Earnings Growth & ADPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.32 per share.
Omnicell Earnings Growth & OMCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.16 per share.
Adaptive Biotechnologies Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Omnicell Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||